Back to Selection     Print       Date : 31 Mar 2025
Fund Summary
UTI Focused Fund (G)
[Equity: Focused]  
 
Fund Details
Fund Type Growth Launch Date 25-Aug-2021
Corpus(Cr.) 2497.0 Latest NAV 15.2214 As on 30-05-2025
Equity(%) 97.73 52 Week High 16.9563
Debt(%) 2.27 52 Week Low 13.6047
Others(%) 0.0 Exit Load 1% for redemption within 365 days
Minimum Investment - Availability
Entry Load Nil Expense Ratio(%) 1.99
Scheme Benchmark NIFTY 500 TRI Broader Benchmark NSE - Nifty 50 TRI
Fund Manager Vishal Chopda
 
Riskometer
Investors understand that their principal will be at Very High risk
 
Scheme Objective
The scheme seeks to generate long term capital appreciation by investing in equity & equity related instruments of maximum 30 stocks across market caps.

Portfolio Classification
 
Asset Mix
 
Concentration Analysis
Top 5 Holdings 35.50%
Top 10 Holdings 53.69%
Top 25 Holdings 91.93%
 
Sector Analysis
Sector/Ratings Net Asset(%)
Banking & Financial 21.51
Retail 13.25
Software & Services 9.42
Automobile 7.62
Finance & Investments 7.21
Telecom 5.29
Healthcare 3.95
Consumer Durables 3.88
SERVICES 3.19
Aerospace & Defence 3.1
Petroleum Products 2.99
Miscellaneous 2.87
Energy 2.58
Ferrous Metals 2.29
Cash 2.26
Pharma & Biotech 2.21
Oil & GAS 1.77
Construction 1.65
Industrial Products 1.51
Fertilisers 1.44
Others 0.01
 
 
 
 
 
Portfolio Metrics
PB Ratio 4.39
PE Ratio 25.55
 
Top 25 Holdings
Holdings Net Asset(%)
HDFC Bank Limited 9.99
ICICI Bank Limited 9.83
Infosys Limited 6.07
Bharti Airtel Limited 5.29
Godrej Consumer Products Limited 4.32
Bajaj Finance Limited 4.12
Havells India Limited 3.88
Avenue Supermarts Limited 3.65
Larsen & Toubro Infotech Ltd 3.35
Jubilant Foodworks Limited 3.19
Bharat Electronics Limited 3.10
Maruti Suzuki India Limited 3.09
Cholamandalam Invest & Finance Co Ltd 3.09
Reliance Industries Limited 2.99
ICICI LOMBARD GENERAL INSURANC 2.87
Trent Limited 2.67
Phoenix Mills Limited 2.61
NTPC Limited 2.58
Hero MotoCorp Limited 2.31
Tata Steel Limited 2.29
NET CURRENT ASSETS 2.26
Tube Investments of India Limited 2.22
Ajanta Pharma Limited 2.21
Aster DM Healthcare Limited 2.03
Syngene International Limited 1.92

Performance Analysis
 
Short Terms Returns
1 Month 3 Month 6 Month 1 Year
2.34% 11.88% -0.37% 7.88%
 
Broader Market Benchmark [NSE - Nifty 50 TRI]
1.92% 12.13% 3.05% 11.08%
 
Scheme Benchmark [NSE - Nifty 500 TRI]
3.65% 14.89% 0.87% 9.02%
 
Long term Returns
2 Year 3 Year 5 Year 10 Year
18.64% 17.00% 0.00% 0.00%
 
 
16.89% 15.56% 22.29% 12.73%
 
 
21.39% 18.44% 25.09% 13.85%
 
Cumulative Performance of Last 5 Years
 
Calendar Year Returns

Risk Analysis
 
Absolute Metrics (Single Computation - last 3 years)
Scheme Name Standard Deviation Sharpe Ratio Downside Deviation Downside Probability Sortino Ratio
 
Benchmark Relative Metrics (Single Computation - last 3 years)
Scheme Name Alpha Beta Treynor Ratio Tracking Error Information Ratio
 
Back to Selection